Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-Cas9 lipid nanoparticles for targeting cyclin-dependent kinases in the tumor microenvironment. | Biotechnol Prog | 2026 | 41606801 | PubTator, text mining | PubMed |
| Exercise-derived extracellular vesicles in oncology: a new frontier for translational nanomedicine. | J Transl Med | 2026 | 41606592 | PubTator, text mining | PubMed |
| NUSAP1 Drives Endometrial Carcinoma via IP3R Phosphorylation, Calcium Dyshomeostasis, and ER-Stress-Mediated Apoptosis. | ACS Omega | 2026 | 41585655 | PubTator, text mining | PubMed |
| Intranasal delivery of Odorranalectin-modified lipid nanoparticles for multi-targeted therapy of Alzheimer's disease. | Mater Today Bio | 2026 | 41560836 | PubTator, text mining | PubMed |
| Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. | Sci Rep | 2026 | 41535376 | PubTator, text mining | PubMed |
| Strong and early immune responses against SARS-CoV-2 in mice and rhesus macaques after BNT162b3 vaccination. | NPJ Vaccines | 2026 | 41530185 | PubTator, text mining | PubMed |
| Distinct innate immune activation profiles of an mRNA-lipid nanoparticle vaccine compared to the empty lipid nanoparticle. | Vaccine | 2026 | 41389658 | PubTator, text mining | PubMed |
| NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression. | Adv Sci (Weinh) | 2026 | 41178464 | PubTator, text mining | PubMed |
| Nanotech meets antibiotics: nucleotide antibiotics delivered by lipid nanoparticles. | Front Cell Infect Microbiol | 2025 | 41808771 | PubTator, text mining | PubMed |
| [Polyarteritis nodosa: an etiology of myelitis that should not be ignored in subsaharansub-Saharan Africa]. | Med Trop Sante Int | 2025 | 41768948 | PubTator, text mining | PubMed |
| mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | 41766818 | PubTator, text mining | PubMed |
| Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions. | In Vitro Model | 2025 | 41710557 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Associated with the Development of Cervical Cancer. | Int J Mol Sci | 2025 | 41516135 | PubTator, text mining | PubMed |
| Cell-DINO: Self-supervised image-based embeddings for cell fluorescent microscopy. | PLoS Comput Biol | 2025 | 41460955 | PubTator, text mining | PubMed |
| Discovery of Essential Genes as Possible Targets for Prostate Cancer Drug Development. | Int J Genomics | 2025 | 41446353 | PubTator, text mining | PubMed |
| Comprehensive analysis of metabolism-related genes in sepsis reveals metabolic-immune heterogeneity and highlights GYG1 as a potential therapeutic target. | Front Immunol | 2025 | 41333476 | PubTator, text mining | PubMed |
| Prognostic value of fatty acid metabolism-related signature and integrated analysis of the immune microenvironment in multiple myeloma. | BMC Cancer | 2025 | 41206460 | PubTator, text mining | PubMed |
| Decoding Cervical Cancer Biomarkers: An Integrated Framework of Bioinformatics, Machine Learning, and Experimental Confirmation. | Cancer Invest | 2025 | 41123057 | PubTator, text mining | PubMed |
| Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo. | Nat Commun | 2025 | 41027853 | PubTator, text mining | PubMed |
| Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations. | Nucleic Acids Res | 2025 | 41020498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers?page=3